The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"SH3 Domains
".
FunFam 152: Tyrosine-protein kinase
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 38 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
7 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06240 (/IDA) Q01621 (/IDA) |
CD4 receptor binding GO:0042609
Interacting selectively and non-covalently with a CD4, a receptor found on the surface of T cells, monocytes and macrophages.
|
7 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06240 (/IPI) W5U6C9 (/IPI) |
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
6 | P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06240 (/IMP) |
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Protein serine/threonine phosphatase activity GO:0004722
Catalysis of the reaction: protein serine phosphate + H2O = protein serine + phosphate, and protein threonine phosphate + H2O = protein threonine + phosphate.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
6 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06240 (/IPI) |
Protein phosphatase binding GO:0019903
Interacting selectively and non-covalently with any protein phosphatase.
|
6 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06240 (/IPI) |
SH2 domain binding GO:0042169
Interacting selectively and non-covalently with a SH2 domain (Src homology 2) of a protein, a protein domain of about 100 amino-acid residues and belonging to the alpha + beta domain class.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
T cell receptor binding GO:0042608
Interacting selectively and non-covalently with a T cell receptor, the antigen-recognizing receptor on the surface of T cells.
|
6 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) W5U6C9 (/IPI) |
Phosphotyrosine residue binding GO:0001784
Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
|
5 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) |
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
5 | P06239 (/EXP) P06239 (/EXP) P06239 (/EXP) P06239 (/EXP) P06239 (/EXP) |
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
5 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) |
Protein serine/threonine phosphatase activity GO:0004722
Catalysis of the reaction: protein serine phosphate + H2O = protein serine + phosphate, and protein threonine phosphate + H2O = protein threonine + phosphate.
|
5 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) |
Protein C-terminus binding GO:0008022
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
5 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
5 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) |
SH2 domain binding GO:0042169
Interacting selectively and non-covalently with a SH2 domain (Src homology 2) of a protein, a protein domain of about 100 amino-acid residues and belonging to the alpha + beta domain class.
|
5 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) |
CD8 receptor binding GO:0042610
Interacting selectively and non-covalently with a CD8, a receptor found on the surface of thymocytes and cytotoxic and suppressor T-lymphocytes.
|
5 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
5 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) |
Phosphatidylinositol 3-kinase binding GO:0043548
Interacting selectively and non-covalently with a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring.
|
5 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) |
ATPase binding GO:0051117
Interacting selectively and non-covalently with an ATPase, any enzyme that catalyzes the hydrolysis of ATP.
|
5 | P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) P06239 (/IPI) |
Phosphotyrosine residue binding GO:0001784
Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
|
1 | P06240 (/ISO) |
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
1 | Q01621 (/IPI) |
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
1 | P06240 (/ISO) |
Protein tyrosine kinase activity GO:0004713
Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
1 | P06240 (/ISO) |
Protein serine/threonine phosphatase activity GO:0004722
Catalysis of the reaction: protein serine phosphate + H2O = protein serine + phosphate, and protein threonine phosphate + H2O = protein threonine + phosphate.
|
1 | P06240 (/ISO) |
Protein C-terminus binding GO:0008022
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
1 | P06240 (/ISO) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
1 | P06240 (/ISO) |
Protein phosphatase binding GO:0019903
Interacting selectively and non-covalently with any protein phosphatase.
|
1 | P06240 (/ISO) |
SH2 domain binding GO:0042169
Interacting selectively and non-covalently with a SH2 domain (Src homology 2) of a protein, a protein domain of about 100 amino-acid residues and belonging to the alpha + beta domain class.
|
1 | P06240 (/ISO) |
T cell receptor binding GO:0042608
Interacting selectively and non-covalently with a T cell receptor, the antigen-recognizing receptor on the surface of T cells.
|
1 | P06240 (/ISO) |
CD4 receptor binding GO:0042609
Interacting selectively and non-covalently with a CD4, a receptor found on the surface of T cells, monocytes and macrophages.
|
1 | P06240 (/ISO) |
CD8 receptor binding GO:0042610
Interacting selectively and non-covalently with a CD8, a receptor found on the surface of thymocytes and cytotoxic and suppressor T-lymphocytes.
|
1 | P06240 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
1 | P06240 (/ISO) |
Phosphatidylinositol 3-kinase binding GO:0043548
Interacting selectively and non-covalently with a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring.
|
1 | P06240 (/ISO) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | Q01621 (/IDA) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | P06240 (/ISO) |
ATPase binding GO:0051117
Interacting selectively and non-covalently with an ATPase, any enzyme that catalyzes the hydrolysis of ATP.
|
1 | P06240 (/ISO) |
Protein antigen binding GO:1990405
Interacting selectively and non-covalently with a protein antigen.
|
1 | P06240 (/IPI) |
There are 57 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
6 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06240 (/IDA) |
Cellular zinc ion homeostasis GO:0006882
Any process involved in the maintenance of an internal steady state of zinc ions at the level of a cell.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
T cell differentiation GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Positive regulation of T cell activation GO:0050870
Any process that activates or increases the frequency, rate or extent of T cell activation.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Positive regulation of intrinsic apoptotic signaling pathway GO:2001244
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Cellular zinc ion homeostasis GO:0006882
Any process involved in the maintenance of an internal steady state of zinc ions at the level of a cell.
|
5 | P06239 (/IEP) P06239 (/IEP) P06239 (/IEP) P06239 (/IEP) P06239 (/IEP) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
5 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) |
Peptidyl-tyrosine phosphorylation GO:0018108
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
|
5 | P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) |
Hemopoiesis GO:0030097
The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates.
|
5 | P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) |
Platelet activation GO:0030168
A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
|
5 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) |
T cell differentiation GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
|
5 | P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) |
T cell costimulation GO:0031295
The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation.
|
5 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
5 | P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
5 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) |
Regulation of defense response to virus by virus GO:0050690
Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism.
|
5 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) |
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
|
5 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) |
Positive regulation of T cell receptor signaling pathway GO:0050862
Any process that activates or increases the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
5 | P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) |
Positive regulation of T cell activation GO:0050870
Any process that activates or increases the frequency, rate or extent of T cell activation.
|
5 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) |
Leukocyte migration GO:0050900
The movement of a leukocyte within or between different tissues and organs of the body.
|
5 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) |
Release of sequestered calcium ion into cytosol GO:0051209
The process in which calcium ions sequestered in the endoplasmic reticulum, Golgi apparatus or mitochondria are released into the cytosolic compartment.
|
5 | P06239 (/ISS) P06239 (/ISS) P06239 (/ISS) P06239 (/ISS) P06239 (/ISS) |
Regulation of lymphocyte activation GO:0051249
Any process that modulates the frequency, rate or extent of lymphocyte activation.
|
5 | P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) P06239 (/NAS) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
5 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) |
Positive regulation of leukocyte cell-cell adhesion GO:1903039
Any process that activates or increases the frequency, rate or extent of leukocyte cell-cell adhesion.
|
5 | P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) |
Positive regulation of intrinsic apoptotic signaling pathway GO:2001244
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
5 | P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) P06239 (/IMP) |
Peptidyl-tyrosine phosphorylation GO:0018108
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
|
2 | P06240 (/IDA) Q01621 (/IDA) |
Protein autophosphorylation GO:0046777
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
|
2 | P06240 (/IDA) Q01621 (/IDA) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
1 | P06240 (/ISO) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
1 | Q01621 (/IEP) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
1 | P06240 (/ISO) |
Cell surface receptor signaling pathway GO:0007166
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
1 | P06240 (/IDA) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | Q01621 (/IEP) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | Q01621 (/IMP) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P06240 (/ISO) |
Response to metal ion GO:0010038
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus.
|
1 | Q01621 (/IDA) |
Response to metal ion GO:0010038
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus.
|
1 | P06240 (/ISO) |
Response to zinc ion GO:0010043
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus.
|
1 | Q01621 (/IEP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | P06240 (/IDA) |
Peptidyl-tyrosine phosphorylation GO:0018108
The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
|
1 | P06240 (/ISO) |
T cell differentiation GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
|
1 | P06240 (/ISO) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
1 | P06240 (/ISO) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P06240 (/ISO) |
Positive regulation of tyrosine phosphorylation of STAT protein GO:0042531
Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
|
1 | P06240 (/IDA) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | Q01621 (/IDA) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | P06240 (/ISO) |
Positive regulation of gamma-delta T cell differentiation GO:0045588
Any process that activates or increases the frequency, rate or extent of gamma-delta T cell differentiation.
|
1 | P06240 (/IMP) |
Regulation of regulatory T cell differentiation GO:0045589
Any process that modulates the frequency, rate or extent of differentiation of regulatory T cells.
|
1 | P06240 (/IGI) |
Protein autophosphorylation GO:0046777
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
|
1 | P06240 (/ISO) |
B cell receptor signaling pathway GO:0050853
A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.
|
1 | P06240 (/IDA) |
Regulation of T cell receptor signaling pathway GO:0050856
Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
|
1 | P06240 (/IDA) |
Positive regulation of T cell activation GO:0050870
Any process that activates or increases the frequency, rate or extent of T cell activation.
|
1 | P06240 (/ISO) |
Release of sequestered calcium ion into cytosol GO:0051209
The process in which calcium ions sequestered in the endoplasmic reticulum, Golgi apparatus or mitochondria are released into the cytosolic compartment.
|
1 | P06240 (/IDA) |
Positive regulation of uterine smooth muscle contraction GO:0070474
Any process that increases the frequency, rate or extent of uterine smooth muscle contraction.
|
1 | Q01621 (/IMP) |
Positive regulation of uterine smooth muscle contraction GO:0070474
Any process that increases the frequency, rate or extent of uterine smooth muscle contraction.
|
1 | P06240 (/ISO) |
Positive regulation of leukocyte cell-cell adhesion GO:1903039
Any process that activates or increases the frequency, rate or extent of leukocyte cell-cell adhesion.
|
1 | P06240 (/ISO) |
Positive regulation of intrinsic apoptotic signaling pathway GO:2001244
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
1 | P06240 (/ISO) |
There are 21 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
7 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) Q01621 (/IDA) W5U6C9 (/IDA) |
Pericentriolar material GO:0000242
A network of small fibers that surrounds the centrioles in cells; contains the microtubule nucleating activity of the centrosome.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
6 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06240 (/TAS) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
6 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) Q01621 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
6 | P06240 (/ISS) P42683 (/ISS) Q3ZCM0 (/ISS) Q5PXS1 (/ISS) Q95KR7 (/ISS) Q95M32 (/ISS) |
Pericentriolar material GO:0000242
A network of small fibers that surrounds the centrioles in cells; contains the microtubule nucleating activity of the centrosome.
|
5 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) |
Immunological synapse GO:0001772
An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
|
5 | P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) P06239 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
5 | P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) P06239 (/TAS) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
5 | P06239 (/HDA) P06239 (/HDA) P06239 (/HDA) P06239 (/HDA) P06239 (/HDA) |
Pericentriolar material GO:0000242
A network of small fibers that surrounds the centrioles in cells; contains the microtubule nucleating activity of the centrosome.
|
1 | P06240 (/ISO) |
Immunological synapse GO:0001772
An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
|
1 | P06240 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | W5U6C9 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
1 | P06240 (/ISO) |
Cell-cell junction GO:0005911
A cell junction that forms a connection between two or more cells in a multicellular organism; excludes direct cytoplasmic junctions such as ring canals.
|
1 | P06240 (/IDA) |
Endocytic vesicle GO:0030139
A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.
|
1 | Q01621 (/IDA) |
Endocytic vesicle GO:0030139
A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.
|
1 | P06240 (/ISO) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | P06240 (/ISO) |
Glutamatergic synapse GO:0098978
A synapse that uses glutamate as a neurotransmitter.
|
1 | Q01621 (/IDA) |
Glutamatergic synapse GO:0098978
A synapse that uses glutamate as a neurotransmitter.
|
1 | P06240 (/ISO) |
Postsynaptic specialization, intracellular component GO:0099091
A network of proteins adjacent to the postsynaptic membrane. Its major components include the proteins that spatially and functionally organize neurotransmitter receptors in the adjacent membrane, such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
1 | Q01621 (/IDA) |
Postsynaptic specialization, intracellular component GO:0099091
A network of proteins adjacent to the postsynaptic membrane. Its major components include the proteins that spatially and functionally organize neurotransmitter receptors in the adjacent membrane, such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
1 | P06240 (/ISO) |